Jun 27, 2025, 05:35
Top Biotechs at ASCO: Kohkan Shamsi on How RadMD Delivers Imaging for Cancer Drug Development
In this episode of Top Biotechs at ASCO, recorded at ASCO 2025, Dr. Kohkan Shamsi, Co-founder of RadMD, discusses how the company provides full-service CoreLab imaging solutions for global cancer trials.
RadMD supports pharma, biotech, and AI companies, managing the entire imaging workflow — from data collection and validation to image reading — with a network of over 350 radiologists across the US, Asia, Latin America, and Europe. The company is led by in-house radiologists and has been audited three times by the FDA with no findings.
Dr. Shamsi also shares why ASCO remains a key platform for advancing cancer therapies and why high-quality imaging is critical to supporting oncology clinical research.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 3, 2025, 09:39
Sep 3, 2025, 09:15
Sep 3, 2025, 09:13